AUSTIN, Texas--(BUSINESS WIRE)--Anebulo Pharmaceuticals, Inc. (Nasdaq: ANEB), a clinical-stage biopharmaceutical company developing novel solutions for people suffering from acute cannabinoid-induced ...

CHS is a condition marked by abdominal pain, nausea, and persistent vomiting linked to prolonged heavy cannabis use. This ...

A study published in the Clinical Toxicology examined ocular measures as evidence of cannabis-induced impairment and found that pupil size is not predictive of acute cannabis exposure. The findings ...

Anebulo's total operating expenses in Q2 were $2.8 million compared with $3.8 million in the same period of last year. Net loss was $2.7 million, or $0.11 per share, compared with a net loss of $3.8 ...

A new study published in Neuropsychopharmacology has found that cannabis intoxication leads to distinct metabolic changes in ...

CLEVELAND, Ohio — When it comes to enforcing drunken driving laws, police have a battery of tools at their disposal. Field sobriety tests, along with breath, blood, and urine tests for blood alcohol ...

A new study found a link between medical cannabis laws and increased rates of cannabis use disorder and cannabis poisoning in the US. The research was published in JAMA Psychiatry. Recent years have ...

AUSTIN, Texas--(BUSINESS WIRE)-- Anebulo Pharmaceuticals, Inc. (ANEB), a clinical-stage biopharmaceutical company developing novel solutions for people suffering from acute cannabinoid-induced ...